"Amikacin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A broad-spectrum antibiotic derived from KANAMYCIN. It is reno- and oto-toxic like the other aminoglycoside antibiotics.
Descriptor ID |
D000583
|
MeSH Number(s) |
D09.408.051.476.060
|
Concept/Terms |
Amikin- Amikin
- Biklin
- Biclin
- Amiklin
- Amukin
BB-K8- BB-K8
- BB K8
- BBK8
- BB-K 8
- BB K 8
- BBK 8
|
Below are MeSH descriptors whose meaning is more general than "Amikacin".
Below are MeSH descriptors whose meaning is more specific than "Amikacin".
This graph shows the total number of publications written about "Amikacin" by people in this website by year, and whether "Amikacin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1996 | 0 | 1 | 1 |
1998 | 1 | 0 | 1 |
2007 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Amikacin" by people in Profiles.
-
The green cerebrospinal fluid. Am J Med. 2011 May; 124(5):411-3.
-
An evaluation of amikacin nephrotoxicity in the hematology/oncology population. Am J Ther. 2008 Mar-Apr; 15(2):131-6.
-
Cerebral abscess caused by Serratia marcescens in a premature neonate. Arq Neuropsiquiatr. 2007 Dec; 65(4A):1018-21.
-
Aerosolized antimicrobials: another look. Crit Care Med. 1998 Jan; 26(1):5-6.
-
Antimicrobial resistance rates among aerobic gram-negative bacilli recovered from patients in intensive care units: evaluation of a national postmarketing surveillance program. Clin Infect Dis. 1996 Oct; 23(4):779-84.
-
Differences in release of tumor necrosis factor from THP-1 cells stimulated by filtrates of antibiotic-killed Escherichia coli. J Infect Dis. 1991 Oct; 164(4):800-2.
-
Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin. Arch Intern Med. 1991 Mar; 151(3):582-5.
-
Multicenter, randomized trial of ciprofloxacin plus azlocillin versus ceftazidime plus amikacin for empiric treatment of febrile neutropenic patients. Am J Med. 1989 Nov 30; 87(5A):278S-282S.
-
Endemic aminoglycoside resistance in gram-negative bacilli: epidemiology and mechanisms. J Infect Dis. 1980 Mar; 141(3):338-45.